 |
Manufacturing TomorrowAuthor: Ohio Manufacturing Institute
Manufacturing Tomorrow is a podcast series brought to you by the Ohio Manufacturing Institute at The Ohio State University. Featuring the perspectives of manufacturing leaders, we focus on the advanced manufacturing innovations, solutions and partnerships that exist in our region now and that will propel industry in the future.Our guests include the unsung heroes of advanced manufacturing, from company C-suite executives and engineers to industry-facing academics, supportive government agencies and regional economic development organizations. Interviews cover the latest topics on products, processes and groundbreaking relationships the best manufacturers engage in to infuse entrepreneurialism in their daily operations.Our mission is simple: to provide a voice to manufacturers to educate the public on the value of manufacturing innovation to the U.S. economy and to showcase how Ohios technology resource support providers (e.g., higher education, technical centers, and MEPs) boost advanced manufacturing solutions. We ask guest speakers about catalysts needed to collaborate on manufacturing innovation, how to reduce academic-industry barriers, and technical resources that can truly bolster manufacturing productivity. Language: en-us Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Fabian Gerlinghaus, Cellares
Sunday, 12 July, 2026
Fabian Gerlinghaus, CEO and Co-Founder of Cellares, joins MFG TMW to discuss what it takes to manufacture living cell therapies at scale — and why doing it in America matters. Cellares operates the world’s first Integrated Development and Manufacturing Organization for automated cell therapy, runs Smart Factories in South San Francisco and Bridgewater, NJ, and recently earned the FDA’s first-ever Advanced Manufacturing Technology designation. We touch on supply chain security, the workforce implications of an 80% reduction in labor requirements, Cellares’ membership in the New American Industrial Alliance, and what its $600M+ in private capital signals about the future of domestic biomanufacturing. A must-listen for anyone thinking about the future of advanced, automated manufacturing. Keywords: Cell therapy manufacturing, automated biomanufacturing, supply chain security, reshoring / domestic manufacturing
